Transformative Biotech CEO Kevin Kraus represented the company at the Bicoastal Medical Device & Diagnostics Symposium at Aquillius, held in person both in San Diego and Baltimore and connected via Zoom. Kraus presented T-Bio’s molecular diagnostics platform and engaged with investors, entrepreneurs, and service providers across the life sciences ecosystem.
The symposium offered valuable perspective on T-Bio’s science and commercialization strategy as the company continues to advance its DirectAmp™ chemistries and @ANYWHERE™ platform technologies for infectious disease testing.
